Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Stewart

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
BMJ Open|February 3, 2023
Impact of minimum unit pricing on alcohol-related hospital outcomes: systematic reviewTobias Maharaj, Colin Angus, Niamh Fitzgerald, et al.
BMJ Open Gastroenterology|August 5, 2025
Non-invasive fibrosis tools lack clinical utility for identifying advanced fibrosis in Fontan-associated liver disease: a retrospective cohort studyPaul Armstrong, Aoife Moriarty, Robert Hughes, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2024
Capturing the incidence of patient agitation amongst conscious sedation ERCPs and the impact on therapeutic outcomesEoin Keating, Gayle Bennett, Harvey Martir, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2012
Spontaneous clearance of hepatitis C infection after liver transplantation from IL28B rs12979860 CC donorsJun Liong Chin, Ross Mac Nicholas, Jennifer Russell, et al.
Frontiers in Robotics and AI|July 21, 2023
A hybrid soft material robotic end-effector for reversible in-space assembly of strut componentsMaxwell Hammond, Anthony Dempsey, William Ward, et al.
Journal of Hepatology|May 29, 2007
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitisStephen Stewart, Martin Prince, Margaret Bassendine, et al.
Hospitals & Health Networks|February 19, 2013
Technology as an enabler of changePamela McNutt, Stephen Stewart, Allana Cummings, et al.
Acta Haematologica|October 4, 2014
Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centreEleanor Ryan, John D Ryan, Jennifer Russell, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2016
Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activationKarl Egan, Audrey Dillon, Eimear Dunne, et al.
BMC Cancer|July 22, 2008
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseGary Beale, Dipankar Chattopadhyay, Joe Gray, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
BMJ Open|February 3, 2023
Impact of minimum unit pricing on alcohol-related hospital outcomes: systematic reviewTobias Maharaj, Colin Angus, Niamh Fitzgerald, et al.
BMJ Open Gastroenterology|August 5, 2025
Non-invasive fibrosis tools lack clinical utility for identifying advanced fibrosis in Fontan-associated liver disease: a retrospective cohort studyPaul Armstrong, Aoife Moriarty, Robert Hughes, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2024
Capturing the incidence of patient agitation amongst conscious sedation ERCPs and the impact on therapeutic outcomesEoin Keating, Gayle Bennett, Harvey Martir, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2012
Spontaneous clearance of hepatitis C infection after liver transplantation from IL28B rs12979860 CC donorsJun Liong Chin, Ross Mac Nicholas, Jennifer Russell, et al.
Frontiers in Robotics and AI|July 21, 2023
A hybrid soft material robotic end-effector for reversible in-space assembly of strut componentsMaxwell Hammond, Anthony Dempsey, William Ward, et al.
Journal of Hepatology|May 29, 2007
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitisStephen Stewart, Martin Prince, Margaret Bassendine, et al.
Hospitals & Health Networks|February 19, 2013
Technology as an enabler of changePamela McNutt, Stephen Stewart, Allana Cummings, et al.
Acta Haematologica|October 4, 2014
Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centreEleanor Ryan, John D Ryan, Jennifer Russell, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2016
Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activationKarl Egan, Audrey Dillon, Eimear Dunne, et al.
BMC Cancer|July 22, 2008
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseGary Beale, Dipankar Chattopadhyay, Joe Gray, et al.
Pageof 7